Actively Recruiting
Comparison of Analgesic Efficacy of Pericapsular Nerve Group (PENG) Block With Lateral Femoral Cutaneous Nerve Block (LFCB) Versus Lumbar and Sacral Erector Spinae Plane Blocks (L-ESPB and S-ESPB) in Pediatric Hip Surgery: A Randomized Controlled Trial
Led by Poznan University of Medical Sciences · Updated on 2025-07-11
60
Participants Needed
1
Research Sites
4 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This research aims to compare the pain relief effectiveness of two regional anesthesia methods in children aged 2 to 16 undergoing hip surgery. The trial focuses on pediatric patients having orthopedic hip procedures such as osteotomies and reconstructive surgeries, where managing postoperative pain is vital to reduce surgical stress, speed recovery, and limit opioid use. The study evaluates whether combining dexamethasone and dexmedetomidine as adjuvants improves outcomes, guiding better pain management in pediatric hip surgery. Two groups are compared: one receives the pericapsular nerve group (PENG) block combined with the lateral femoral cutaneous nerve block (LFCB) using ultrasound guidance and ropivacaine at specified doses. The other group receives lumbar and sacral erector spinae plane blocks (L-ESPB and S-ESPB), also guided by ultrasound and administered with ropivacaine. Both approaches target nerves supplying the hip region to assess which provides better pain control after surgery. Participants will be monitored for 48 hours after surgery to measure total opioid consumption as the primary outcome. Secondary outcomes include the time to first rescue opioid, pain scores at several time points, and laboratory markers of inflammation. Safety and effectiveness are evaluated through pain rating scales and blood tests. The study is randomized and blinded to ensure fair comparison, with care provided under medical supervision throughout the 48-hour postoperative period.
CONDITIONS
Brief Title
PENG With LFCB vs. ESP Blocks for Pediatric Hip Surgery
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Pediatric patients aged between 2 and 16 years
- Scheduled for elective orthopedic hip surgery including osteotomies and hip reconstruction
- ASA physical status classification I to III
- Written informed consent obtained from the patient's legal guardian(s)
You will not qualify if you...
- Known allergy or hypersensitivity to any study medications
- Infection or inflammation at the intended injection sites
- Coagulopathy or bleeding disorders including use of anticoagulant therapy
- Neurological disorders or peripheral neuropathies affecting sensory or motor assessment
- Cognitive impairment or behavioral disorders affecting pain assessment or cooperation
- History of chronic opioid use or substance abuse
- Severe systemic disease compromising safety or study adherence
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Surgery day and immediate postoperative period
Participants receive regional anesthesia blocks with ropivacaine during pediatric hip surgery to manage postoperative pain.
1 surgical visit (in-person)
Duration - 48 hours after surgery
Participants are monitored for pain levels and opioid use during the 48 hours after surgery.
Assessments at 4, 8, 12, 24, and 48 hours post-surgery
Trial Site Locations
Total: 1 location
1
Poznan University of Medical Sciences
Poznan, Poland
Actively Recruiting
Research Team
M
Malgorzata Reysner
How is the study designed?
Study Type
INTERVENTIONAL
Masking
QUADRUPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
TREATMENT
Number of Arms
2
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here